Hyperthermic Isolated Limb Perfusion With Tumor Necrosis Factor-α and Melphalan in Advanced Soft-Tissue Sarcomas: Histopathological Considerations

被引：0
|
作者：
Josephine Issakov
Ofer Merimsky
Mordechai Gutman
Yehuda Kollender
Dina Lev-Chelouche
Soubhi Abu-Abid
Beatriz Lifschitz-Mercer
Moshe Inbar
Joseph M. Klausner
Isaac Meller
机构：
[1] Tel-Aviv Sourasky Medical Center,Department of Pathology and Unit of Bone and Soft Tissue Pathology
[2] Affiliated with Sackler Faculty of Medicine,Departments of Oncology
[3] Tel-Aviv University,Departments of Surgery
[4] Tel-Aviv Sourasky Medical Center Affiliated with Sackler Faculty of Medicine,National Unit of Orthopedic Oncology
[5] Tel-Aviv University,undefined
[6] Tel-Aviv Sourasky Medical Center Affiliated with Sackler Faculty of Medicine,undefined
[7] Tel-Aviv University,undefined
[8] Tel-Aviv Sourasky Medical Center Affiliated with Sackler Faculty of Medicine,undefined
[9] Tel-Aviv University,undefined
来源：
Annals of Surgical Oncology | 2000年 / 7卷
关键词：
TNF-α; Isolated limb perfusion; Soft-tissue sarcoma; Neoadjuvant treatment.;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background: Hyperthermic isolated limb perfusion with tumor necrosis factor-α and melphalan was used as induction treatment in locally advanced extremity soft-tissue sarcomas for limb sparing surgery. The typical histopathological changes that occur in these tumoral masses are described in a series of 30 patients.
引用
下载
收藏
页码：155 / 159
页数：4
相关论文
共 50 条
  • [1] Hyperthermic isolated limb perfusion with tumor necrosis factor-α and melphalan in advanced soft-tissue sarcomas:: Histopathological considerations
    Issakov, J
    Merimsky, O
    Gutman, M
    Kollender, Y
    Lev-Chelouche, D
    Abu-Abid, S
    Lifschitz-Mercer, B
    Inbar, M
    Klausner, JM
    Meller, I
    ANNALS OF SURGICAL ONCOLOGY, 2000, 7 (02) : 155 - 159
  • [2] Isolated Limb Perfusion With Melphalan and Tumor Necrosis Factor α for Advanced Melanoma and Soft-Tissue Sarcoma
    Andrew J. Hayes
    Susan J. Neuhaus
    Matthew A. Clark
    J. Meirion Thomas
    Annals of Surgical Oncology, 2007, 14 : 230 - 238
  • [3] Isolated limb perfusion with melphalan and tumor necrosis factor α for advanced melanoma and soft-tissue sarcoma
    Hayes, Andrew J.
    Neuhaus, Susan J.
    Clark, Matthew A.
    Thomas, J. Meirion
    ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (01) : 230 - 238
  • [4] Isolated hyperthermic limb perfusion in soft-tissue sarcomas
    Eigler, FW
    Krause, U
    CHIRURG, 1997, 68 (06): : 649 - 649
  • [5] Hyperthermic isolated limb perfusion with tumour necrosis factor and melphalan as treatment of locally advanced or recurrent soft tissue sarcomas of the extremities
    Koops, HS
    Eggermont, AMM
    Liènard, D
    Kroon, BBR
    Hoekstra, HJ
    van Geel, AN
    Nieweg, OE
    Lejeune, FJ
    RADIOTHERAPY AND ONCOLOGY, 1998, 48 (01) : 1 - 4
  • [6] Hyperthermic isolated limb perfusion with tumor necrosis factor-α and melphalan in patients with locally advanced soft tissue sarcomas:: Treatment response and clinical outcome related to changes in proliferation and apoptosis
    Plaat, BEC
    Molenaar, WM
    Mastik, MF
    Koudstaal, J
    van den Berg, E
    Koops, HS
    Hoekstra, HJ
    CLINICAL CANCER RESEARCH, 1999, 5 (07) : 1650 - 1657
  • [7] Angiographic response of locally advanced soft-tissue sarcoma following hyperthermic isolated limb perfusion with tumor necrosis factor
    Olieman, AFT
    vanGinkel, RJ
    Hoekstra, HJ
    Mooyaart, EL
    Molenaar, WM
    Koops, HS
    ANNALS OF SURGICAL ONCOLOGY, 1997, 4 (01) : 64 - 69
  • [8] Angiographic response of locally advanced soft-tissue sarcoma following hyperthermic isolated limb perfusion with tumor necrosis factor
    Annette F. T. Olieman
    Robert J. van Ginkel
    Harald J. Hoekstra
    Eduard L. Mooyaart
    Willemina M. Molenaar
    Heimen Schraffordt Koops
    Annals of Surgical Oncology, 1997, 4 : 64 - 69
  • [9] Hyperthermic isolated limb perfusion with tumour necrosis factor-α and melphalan as palliative limb-saving treatment in patients with locally advanced soft-tissue sarcomas of the extremities with regional or distant metastases.: Is it worthwhile?
    Olieman, AFT
    van Ginkel, RJ
    Molenaar, WM
    Koops, HS
    Hoekstra, HJ
    ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY, 1998, 118 (1-2) : 70 - 74
  • [10] Isolated limb perfusion with tumor necrosis factor-α and melphalan for patients with unresectable soft tissue sarcoma of the extremities
    Noorda, EM
    Vrouenraets, BC
    Nieweg, OE
    van Coevorden, F
    van Slooten, GW
    Kroon, BBR
    CANCER, 2003, 98 (07) : 1483 - 1490
12345